MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
Stock Snapshot
As of today, MannKind(MNKD) shares are valued at $5.57. The company's market cap stands at 1.68B, with a P/E ratio of 57.90.
On 2026-01-24, MannKind(MNKD) stock traded between a low of $5.46 and a high of $5.98. Shares are currently priced at $5.57, which is +2.1% above the low and -6.9% below the high.
MannKind(MNKD) shares are trading with a volume of 4.52M, against a daily average of 4.21M.
During the past year, MannKind(MNKD) stock moved between $3.38 at its lowest and $6.51 at its peak.
During the past year, MannKind(MNKD) stock moved between $3.38 at its lowest and $6.51 at its peak.
MNKD News
MannKind Corporation recently outlined its 2026 growth drivers, emphasizing upcoming FDA milestones for Afrezza, including label updates to simplify adult dosin...
Advertisement Why MannKind (MNKD) is on investors’ radar MannKind (MNKD) has attracted attention after posting annual revenue of US$313.787 million and net in...
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.